Toshiaki Komatsu
Toshiaki Komatsu publishes mostly in Organic Chemistry, Pharmacology and Molecular Biology, on topics such as Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Resistance in Staphylococcus and Chemical Synthesis and Analysis.
- World rank
- #2,656,992 of 7,710,434 ranked researchers
- Rank in Japan
- #55,481 of 383,136
- Works
- 91
- Citations
- 1.1k
- Citations per work
- 11.8
What does Toshiaki Komatsu research?
Toshiaki Komatsu's work is mostly in Medicine (29%), Chemistry (24%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3437.7%
- Health Sciences2729.4%
- Medicine2729.4%
- Physical Sciences2224.3%
- Chemistry2224.3%
- Life Sciences88.6%
- 1Organic Chemistry24% of their works
- 2Pharmacology11% of their works
- 3Molecular Biology9% of their works
- 4Infectious Diseases8% of their works
- 5Surgery6% of their works
- 6Epidemiology5% of their works
Research topics
- Antibiotics Pharmacokinetics and Efficacy
- Antimicrobial Resistance in Staphylococcus
- Chemical Synthesis and Analysis
- Asymmetric Synthesis and Catalysis
- Synthesis of β-Lactam Compounds
- Surgical site infection prevention
- Phenothiazines and Benzothiazines Synthesis and Activities
- Synthesis and Characterization of Heterocyclic Compounds
Which keywords describe Toshiaki Komatsu's research?
The keywords of their largest research topics: Antimicrobial Resistance, Antibiotic Pharmacokinetics, Critically Ill Patients, Healthcare-Associated Infections, Synthesis, Drug Discovery, MRSA and Staphylococcus aureus.
- Scaffold
- Biological Activities
- Stereocontrolled Synthesis
- Antimicrobial Prophylaxis
- Enantioselective Reactions
- Foldamers
- Anticancer
- Staphylococcus aureus
- Drug Discovery
- Healthcare-Associated Infections
- Antibiotic Pharmacokinetics
- Antimicrobial Resistance
- Critically Ill Patients
- Synthesis
- MRSA
- Biological Evaluation
- Antimicrobial
- Peptide Synthesis
- Organocatalysis
- Asymmetric Catalysis
- Surgical Site Infection
- Phenothiazines
- Triazines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Antimicrobial Resistance372 topics
- Antibiotic Pharmacokinetics241 topic
- Critically Ill Patients241 topic
- Healthcare-Associated Infections192 topics
- Synthesis163 topics
- Drug Discovery132 topics
- MRSA131 topic
- Staphylococcus aureus131 topic
- Biological Evaluation112 topics
- Anticancer102 topics
- Antimicrobial102 topics
- Foldamers81 topic
- Peptide Synthesis81 topic
- Enantioselective Reactions71 topic
- Organocatalysis71 topic
- Antimicrobial Prophylaxis61 topic
- Asymmetric Catalysis61 topic
- Stereocontrolled Synthesis61 topic
- Surgical Site Infection61 topic
- Biological Activities51 topic
- Phenothiazines51 topic
- Scaffold51 topic
- Triazines51 topic
Where does Toshiaki Komatsu work?
Toshiaki Komatsu's main affiliation in the publication record is Kitasato University Hospital, Japan.
How many publications and citations does Toshiaki Komatsu have?
OpenAlex counts 91 works and 1,076 citations for Toshiaki Komatsu, an h-index of 16, ranking #2,656,992 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Toshiaki Komatsu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.